$85M raised by Epirium to reverse process of aging
Karma Impact - 18-Dec-2019Company claims its technology reverses decline of mitochondrial function in aging and disease
Join the club for FREE to access the whole archive and other member benefits.
Clinical-stage Biopharmaceutical Company
Clinical stage biopharmaceutical company that has uncovered unique insights into the biology of mitochondrial biogenesis and function, leading to an advanced understanding of its pleotropic clinical effect in disease. These findings have led to the discovery of a novel, previously undescribed pharmacological approach to the treatment of diseases characterized by deficits in these pathways.
Visit website: https://epirium.com/
Details last updated 03-Feb-2020
Company claims its technology reverses decline of mitochondrial function in aging and disease